ConductScience.org, home

Paper8467484

Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.

Murakami H and 5 others. Cancer Res, 1993. Cited by 243 papers, by iCite.

Cite this record

ConductScience Library. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Papers, record 8467484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8467484

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
PubMed
Journal
Cancer Res
PubMed
Year
1993
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
243
iCite
Relative citation ratio, by iCite
4.95
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Murakami HH
2Sanderson NDN D
3Nagy PP
4Marino PAP A
5Merlino GG
6Thorgeirsson SSS S

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CocarcinogenesisMajor topic
Genes, mycMajor topic
Liver Neoplasms, ExperimentalMajor topic
Transforming Growth Factor alphaMajor topic
Animals
Cell Nucleus
Cell Transformation, Neoplastic
Disease Models, Animal
Gene Expression
Male
Mice
Mice, Transgenic
Zinc

Source PubMed

Download CSV of topics

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.

PMIDTitleJournalYearIn PapersSource
42759661Molecular mechanism of augmentation of oncogenic activity of MYC by TAF2 in HCC.J Biol Chem2026https://conductscience.org/library/papers/42759661PubMed
41704422Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma.JHEP Rep2026https://conductscience.org/library/papers/41704422PubMed
40741108The application of liver cancer organoids in tumour precision medicine: A comprehensive review.ILIVER2025https://conductscience.org/library/papers/40741108PubMed
39062197Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges.Biomedicines2024https://conductscience.org/library/papers/39062197PubMed
38889481Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.EBioMedicine2024https://conductscience.org/library/papers/38889481PubMed
38138981New and Old Key Players in Liver Cancer.Int J Mol Sci2023https://conductscience.org/library/papers/38138981PubMed
36982773Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1.Int J Mol Sci2023https://conductscience.org/library/papers/36982773PubMed
36403194WD repeat domain 48 promotes hepatocellular carcinoma progression by stabilizing c-Myc.J Cell Mol Med2022https://conductscience.org/library/papers/36403194PubMed
35847898Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.Front Oncol2022https://conductscience.org/library/papers/35847898PubMed
35633441Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma.Int J Clin Oncol2022https://conductscience.org/library/papers/35633441PubMed
35053588Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors.Cancers (Basel)2022https://conductscience.org/library/papers/35053588PubMed
35008356A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.Cancers (Basel)2021https://conductscience.org/library/papers/35008356PubMed
34771745In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.Cancers (Basel)2021https://conductscience.org/library/papers/34771745PubMed
34758313Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.Cell Rep2021https://conductscience.org/library/papers/34758313PubMed
34464659TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.J Hepatol2022https://conductscience.org/library/papers/34464659PubMed
34353442Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC).Adv Cancer Res2021https://conductscience.org/library/papers/34353442PubMed
32489910A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma.MethodsX2020https://conductscience.org/library/papers/32489910PubMed
32327473Mouse Models of Oncoimmunology in Hepatocellular Carcinoma.Clin Cancer Res2020https://conductscience.org/library/papers/32327473PubMed
32160703Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/32160703PubMed
31861541Genetically Engineered Mouse Models for Liver Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31861541PubMed

See all 104 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8467484

GET https://conductscience.org/api/papers/v1/8467484/cited_by?page=2